The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.
Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.
Our software solutions for proteomics include Spectronaut® for DIA proteomics, SpectroDive™ for Targeted Proteomics, SpectroMine™ for DDA proteomics, and our free-of-charge QC tool QuiC™.